Original ArticleMutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome
Under an Elsevier user license
open archive
Keywords
alternative pathway
complement
complement Factor I
hemolytic and uremic syndrome
thrombotic microangiopathy
Cited by (0)
All the authors declared no competing interests.
- 8
Current address: Novartis Institutes for Biomedical Research, Disease Area Oncology, Basel, Switzerland
Copyright © 2010 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.